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Abstract 
Hypovolemic shock is characterized by an acute failure of the cardiovascular system to 
perfuse the body tissues adequately. If the patient is not resuscitated appropriately, it can 
lead to organ failure and death. It is well known that the body’s compensatory responses 
often maintain an almost normal blood pressure while hemorrhaging. When the blood 
pressure finally decreases, management is much more difficult. Due to high variability, 
the vital signs heart rate and blood pressure is therefore not very sensitive markers of 
evolving hemorrhage. 
In this project we wanted to simulate the development of a hemorrhagic shock by using a 
lower body negative pressure chamber. Simultaneously we recorded several 
cardiovascular variables at a high sampling rate (100 Hz). The idea was to investigate 
whether any of these variables could be used to predict a cardiovascular collapse on an 
early stage.  
10 healthy non-smoking subjects (5 female) were investigated. They were instrumented 
with different cardiovascular and respiratory instruments recording variables like heart  
rate, stroke volume, cardiac output, blood pressure, skin blood flow, respiratory 
movements, concentration of expiratory CO2 and O2 and skin temperature. In addition 
many variables could be calculated, like cardiac output and total peripheral resistance. 
This was a large project involving 6 researchers. More than 6.4 million unique data points 
were collected. In this paper only preliminary results are presented. 
MAP and HR were confirmed to be unreliable as an early marker. SV fell almost linearly 
and can be used, but is difficult to measure. Further investigation of data is necessary 
before conclusions can be drawn. 
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Introduction 
In my project I have worked together with a cardiovascular research group at the 
Department of Physiology, Institute of Basic Medical Sciences, University of Oslo. The 
main research technique is the ultrasound Doppler method for measurement of blood 
flow, but in this particular research project several other research tools have been used. 
 
My role has been to participate together with other students and senior researchers in the 
planning and execution of the study. To illustrate the size of the project, more than 6.4 
million unique data points are collected. The project involves 2 other researchers, 2 
students, and 2 supervisors. We are currently in the process of analyzing the dataset, and 
the first paper is estimated to be in manuscript by December 2010.  
 
The project has been given some attention in the media, and news coverage has been 
given in the radio program “Verdt å vite” in NRK P2 (available as pod cast in iTunes). A 
presentation is also given in the university news paper Apollon (apollon.uio.no) and on 
the internet (http://www.forskning.no/artikler/2009/oktober/232019). I chose to write in 
English because this is the language of the papers that we will try to publish our results. 
 
I present my project in a classic disposition with background, material and methods, 
results, discussion and conclusion. I have added acknowledgements and a reference list. 
The results I present are only preliminary and do not cover the entire specter of data 
collected. Some results are analyzed and used by other students for their project. The 
preliminary results are a result of my independent analyzes, and the final results and 
conclusions of the research group work may therefore differ. I have attached the research 
protocol and the permissions given by the Regional Ethics Committee (REK). 
 
There is a limitation as to how extensive a 12 weeks project can be. I chose to be part of a 
larger project, and therefore the main body of my work so far has been planning and 
execution. A lot of work remains to be done, but this will hopefully result in my first 
publications. This paper is a summary of my work so far, and this is reflected on the 
focus of this paper.  
 
Abbreviations: 
MAP – mean arterial pressure 
SP – systolic pressure 
DP – diastolic pressure 
CO – cardiac output 
SV – stroke volume 
HR – heart rate 
TPR – total peripheral resistance 
LBNP – lower body negative pressure 
ECG – electrocardiogram 
SkBF – skin blood flow 
FVR – forearm vascular resistance  
LDF-fing  –  laser Doppler flowmetry finger 
LDF-nas  –  laser Doppler flowmetry non-acral skin 
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Background 
Clinical shock is characterized by acute failure of the cardiovascular system to perfuse 
the tissues of the body adequately. If it is not treated appropriate, it can lead to organ 
failure and death. Hypovolemic shock is most common, and is caused by a fall in blood 
or plasma volume, which may be due to external or internal fluid loss.  It’s well known 
that the body’s compensatory responses maintain an almost normal blood pressure while 
bleeding. When the blood pressure starts to fall, it can be too late to start treatment. In 
acute medicine it is desirable to prove a threatening shock early, so a proper treatment 
can be provided as soon as possible. 
 
A rapid 20-30% blood loss may or may not reduce the mean arterial pressure, depending 
on the compensatory responses, but it causes clinical shock. With prompt treatment a 20-
30% blood loss in not usually life-threatening. A 30-40% blood loss reduces arterial 
pressure to 50-70 mmHg, and causes severe sometimes irreversible shock, with anuria 
and impaired coronary and cerebral perfusion.  
 
The immediate effect of acute hypovolemia is to reduce the central blood volume and the 
ventricular end-diastolic volume. This reduces the contractile energy through the Starling 
mechanism, so the stroke volume and pulse pressure decline. 
A set of reflex responses helps to support the arterial pressure in shock, and maintain the 
cerebral and myocardial perfusion. The activity of cardiopulmonary stretch receptors and 
arterial baroreceptors declines or ceases. Arterial chemoreceptor activity is raised by a 
metabolic acidosis and by reduced chemoreceptor perfusion. The arterial chemoreflex 
input drives the rapid ventilation of shock. 
The body defenses during a compensated, non-hypotensive hypovolemia occurs over 
three time scales:  
Rapid reflexes that act within seconds: 
A reflex increase in sympathetic vasomotor activity constricts the resistance vessels in the 
coetaneous, skeletal muscle, splanchnic and renal vascular beds. The resulting increased 
total peripheral resistance provides immediate support to the arterial pressure. 
Reflex venoconstriction in the splanchnic and coetaneous circulations partially restores 
the thoracic blood volume and cardiac filling pressure.  
The reduction of cardiac output is partly counteracted by increased cardiac sympathetic 
activity, which causes tachycardia and enhances myocardial contractility. 
The sympathetic-mediated responses are reinforced by increased levels of circulating 
vasoconstrictor hormones (angiotensin II, adrenaline, noradrenaline and vasopressin). 
Because of the compensation provided by the increased peripheral resistance, reduced 
venous capacitance and increased cardiac performance, mean arterial pressure may be 
well maintained in a moderate hemorrhage. This means that arterial blood pressure is not 
a reliable index of blood loss. 
Intermediate responses that act over 5-60 min: 
The fall in venous pressure and the sympathetic mediated reduction in capillary blood 
pressure allow the plasma colloid osmotic pressure to dominate. This results in a transient 
absorption of interstitial fluid. This internal transfusion of up to 0,5 l of fluid can be 
absorbed into the human vascular compartment within an hour, partially restoring the 
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depleted plasma volume, but reducing the hematocrit and plasma protein concentration. 
The internal transfusion helps to raise the low cardiac filling pressure. The haemodilution 
reduces the blood viscosity and improves tissue perfusion, but also reduces the O2-
carrying capacity of blood.  
In compensated shock the above responses preserve the perfusion of the heart and brain. 
Other organs have a reduced perfusion, due to a subnormal amount of body water, 
electrolytes, plasma protein and red cells. These deficiencies are corrected gradually over 
days (1). 
The vital signs heart frequency and blood pressure can vary considerably when shock is 
evolving, so they are not sensitive enough to show the outcome of a hemorrhage. The last 
years, it’s been a growing interest to identify a cursor for an early point out of threatening 
shocks. A hypothesis is that analysis of the ECG-curve during a threatening shock, could 
be a cursor (2). Recently has pulse pressure and RR-interval variability been launched as 
a promising cursor (3). Probably is a measurement of the cardiac stroke volume better in 
relation to reduction in central blood volume during a hemorrhage (4), but it needs further 
clarification. In studies of experimental bleeding in humans, a model with negative 
pressure over the lower limbs (5). This is called a LBNP (lower body negative pressure). 
– 60 mmHg probably simulates a hemorrhage of 1 – 1,5 liter.  
 
A common list of general features for a definition of shock is as follows: 
Hypotension (sp<100mmHg) 
Tachycardia (>100/min) 
Cold, clammy skin 
Rapid, shallow respiration 
Drowsiness, confusion, irritability 
Oliguria (urine output <30ml/hour) 
Elevated or reduced central pressure  
Multi-organ failure 
 
Clinically it’s also common to use tables to make an early identification of those patients 
who will require critical care. One example is MEWS (Modified Early Warning Score): 
 3 2 1 0 1 2 3 
Respiratory rate  <9  9-14 15-20 21-29 >29 
Heart rate 
(bpm) 
 <40 41-50 51-100 101-110 111-129 >129 
Systolic blood 
pressure 
(mmHg) 
<70 71-80 81-100 101-199  >199  
Temperature 
(C) 
 <35  35-38,4  >38,4  
AVPU score    Alert Reacting 
to voice 
Reacting 
to pain 
Unresponsive 
Table 1: A score of 3 or more means a patient is likely to need urgent assessment, and a 
score of 5 or more indicates that the patient is likely to require critical care usually in 
intensive care unit. 
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Clinically it is also common to use tables to make an early identification of those patients 
who will require critical care. One example is MEWS (Modified Early Warning Score). 
MEWS is a systematic approach to detect early signs of cardiovascular collapse. One 
improvement of this approach would be to have a cardiovascular instrument continuously 
measure one or several variables, and then use an algorithm to warn the doctor or the 
medic that the patient is developing a shock. Pre-hospital medicine is characterized by 
lack of resources, and hostile environments. Therefore can such a device be of outmost 
help. 
The basic idea of our project is therefore to use a reproducible model for human 
hemorrhaging to measure a wide range of cardiovascular variables and analyze them with 
respect to other early signs of shock. We will also try to confirm clinically known 
physiological variables, and use the experience to generate new hypothesis for further 
research.  
Our hypothesis is that there are measurable changes in the circulation on an earlier time 
during shock development than the traditional measurements pulse and blood pressure 
can reveal. Our test protocol will not bring our trial persons to a threatening shock, but 
rather focus on the development prior. Other purposes of the project are to compare three 
different methods for non-invasive measurement of stroke volume. The three methods are 
ultrasound Doppler measured completely proximal in the aorta, estimation of stroke 
volume from the blood pressure curve and finally impedance measurement. I will not 
discuss this part of the project any further, and the data are not ready for analyzes yet. 
 
7/23 
12/6/2010 
Material and methods 
 
General 
All experiments were conducted in a laboratory designed for cardiovascular experiments. 
The room temperature and humidity was stable and similar in all experimental runs. All 
equipment used to measure cardiovascular variables (listed below) was connected to a 
computer through an analog/digital converter. The different variables were recorded and 
also displayed real time. The highest sample frequency was 100 Hz. Many data was also 
recorded heartbeat by heartbeat, gated by the ECG-R wave. All data was stored on the 
computer for recapture later. Since the LBNP chamber is rather noisy, a vacuum cleaner 
was turned on and placed in a corner during the entire experiment. This was done to 
avoid sudden changes in the noise load experienced by the subjects, which could lead to 
unwanted vasoconstriction (6). 
 
Safety 
The negative pressure applied to the subjects could potentially lead to syncope. As a 
precaution a medical doctor with resuscitation capabilities was present at all times. Two 
independent researchers observed the subjects during the experiment, and were able to 
turn of the negative pressure and decompress the chamber within less than a second. An 
observation protocol was made to observe the subjects vital signs, and absolute limits to 
blood pressure was set at 70 mmHg systolic. Dizziness, nausea, cold sweat, warm 
flushes, reduced vision, sudden bradycardia (> 15 beats/min) or sudden drop in blood 
pressure (> 15 mmHg) would prompt a decompression of the chamber to avoid fainting. 
 
Subjects 
The subjects (n = 10) were recruited among healthy non-smoking medical students. They 
were asked not to exercise or drink caffeinated beverages on the day of the experiments 
(12 hrs limit), and no alcohol for the last 24 hours. Since a large meal will increase 
baseline CO (), we also asked the participants not to eat for the last 2 hours before the 
experiment.  
 
 
Lower body negative pressure 
The research group has designed a lower body negative pressure (LBNP) chamber and 
control system that makes it possible to apply LBNP in the range of 0 to – 60 mmHg (7). 
The pressure can be applied either very rapidly (< 300 ms), or more gradually, depending 
on the protocol. The chamber consists of 3 main parts: a tube where the lover part of the 
body is placed, a negative pressure generator and a control system that interfaces with the 
user and monitors the negative pressure. A rubber and neoprene skirt closes the chamber 
around the subject’s waist.  
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Figure 1. LBNP-chamber. Detailed description in the text below. 
 
The LBNP chamber (fig.1.) consists of a bench with a footboard. This is mobile and the 
subjects are placed on the bench and then rolled into the negative pressure chamber. The 
footboard of the bench is adjustable (1). A small wheel (2) that fits the rail at the bottom 
of the tube places the LBNP chamber into the right position. A reservoir tank (3) is 
connected to the transparent PMMA tube (4). A large-diameter hose connects the 
reservoir tank and the tube (5). Sub-atmospheric pressure is generated in the tank and the 
tube by a vacuum cleaner that is insulated and enclosed in the box beside the tank (6). 
With the control box (7) you operate the chamber. An alternative is to use digital signals 
generated from pre-programmed profiles stored in a computer. The PMAA tube lies in a 
soft rubber "cradle" (8). 
 
 
Instrumentation 
 
Ultrasound Doppler  
SD-100 and CFM-750 (GE Vingmed, Horten, Norway), a bidirectional ultrasound 
Doppler velocimeter was used to measure stroke volume. It was operated in the pulsed 
mode with a 2 MHz Doppler probe hand-held at the suprasternal notch. The aim was to 
get an angle of 20 degrees between the sound beam and the direction of the bloodstream 
in the ascending aorta. The sample volume was adjusted so that the measurements were 
made 1-2 cm above the aortic valve. We assumed that the aortic valvular orifice was 
circular, and used this diameter when calculating the SV. SV was then calculated by 
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multiplying the value obtained by numerical integration of the recorded instantaneous 
maximum velocity during each R-R interval by the area of the orifice. This calculation is 
based on the assumption that that the velocity profile is rectangular in that area (8). 
 
To measure the brachial blood flow velocity (SkBF), we used SD-50 (GE Vingmed, 
Horten, Norway) bidirectional ultrasound Doppler velocimeter with a pulsed 10 MHz 
Doppler probe. The circular transducer had a fixed angel of 45° between the sound beam 
and the underlying surface, and was fastened by adhesive tape to the skin in the cubital 
fosse over the brachial artery. The mean velocity signal was transferred to the recording 
computer and the velocity integral was calculated. 
 
ECG 
The subjects were monitored by a three-lead ECG (lead II). All the ultrasound Doppler 
velocimeters (SD-50, SD-100 or CFM-750, Vingmed Sound A/S, Horten Norway) had a 
built inn ECG monitor. The R-wave in the ECG signal was detected for every heartbeat. 
The time interval between each detected R-wave was measured and used to calculate HR.  
 
Laser Doppler 
A laser Doppler flowmeter (MBF3D, Moor Instruments, Devon UK) was used to 
measure blood flow (in arbitrary units) on the finger pulpa, and on non-acral skin on the 
lower arm. The laser Doppler probes were fastened to the skin with double-sided tape. 
The noise limiting filter was set at 21 kHz (highest possible), and emitted wavelength 
was 820 nm.  
 
Continuous finger arterial blood pressure 
We used a Finometer® PRO (FMS, Finapres Medical Systems, Amsterdam, The 
Netherlands) is a stand-alone solution for accurate non-invasive beat-to-beat blood 
pressure monitoring. This instrument requires a finger cuff on one finger, and this finger 
was at heart level during the whole experiment. The Finapres uses a clamp to keep the 
blood volume in the finger constant, and then calculates the finger arterial blood pressure 
by converting the pressure of the clamp (9). The Finometer® PRO is widely used in 
clinical settings and advanced scientific research. The absolute accuracy of the 
Finometer® PRO can be calibrated with an upper arm cuff measurement using the Return 
To Flow (RTF) technology.  
 
Other instruments that was used, but not discussed in this paper 
• respiratory chest volume changes 
• expiratory O2 
• expiratory CO2 
• skin temperature 
• cardiothoracic impedance (TaskForce) 
• SaO2 
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Figure 2. Setup for one experimental run. At least 4 persons had to be present to perform 
the experiment.  
 
 
Cardiovascular variables 
 
SV and HR were calculated from both the ultrasound and the finapres instruments. CO 
was calculated beat by beat from corresponding HR and SV values. TPR was 
calculated by dividing MAP by CO beat by beat, and FVR by dividing MAP by SkBF- 
We had no measure of central venous pressure and calculated resistance by assuming 
central venous pressure and femoral venous pressure to be zero (10). 
 
Cardiovascular variables that was sampled, but not discussed in this paper 
• respiration: rate, depth, frequency, SaO2, expiratory O2 and CO2 
• ultrasound Doppler: aortic blood velocity, stroke length, aortaflow-wave 
• peripheral volume 
• ECG: R-wave height 
• skin temperature 
• SV, HR, CO, TPR ++ from TaskForce. 
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Analysis 
Data handling 
The recording computer received the signals, and different calculations were made by the 
software (version REGIST3, Morten Eriksen, Oslo, Norway), like integration and heart 
rate. The data was then moved to a new computer where they were the sorted and filtered 
(automatic calibration signals from different instruments were removed) in a MathLab® 
designed program. The final data was used for statistics and illustrations. The illustrations 
are drawn in SigmaPlot® 8.0.  
 
Statistical methods 
The statistical tools used are estimation by nonparametric Wilcoxon median. In table 2 
the 95% confidence interval for the Wilcoxon median is presented. 
Possible analysis that is not discussed in this paper 
Spectral analysis of the variations from MAP, ECG and SaO2 signal sampled at 100 HZ 
is not done in my paper.  
 
 
Protocol 
 
The subjects were informed in every detail about the experiment and signed a written 
consent on a separate day prior to the day of the experiment. On the day of the 
experiment, the subjects were lightly dressed, and rested comfortably in the supine 
position on a bench. The bench was adjusted to fit the chamber, and the subjects wore 
warm polar socks to avoid feeling cold from the draft created when the chamber was 
emptied of air. A vacuum cleaner was placed running in a corner, creating a background 
sound resembling the noise of LBNP chamber. The room temperature was adjusted to a 
level where the subjects felt normothermic, having approximately 2-3 opening and 
closing of AVAS pr minute confirmed by ultrasound Doppler measurements (11).   
 
The protocol timeline was as follows (see figure 3): 
 
- 5 minutes baseline readings, pressure 0 mmHg 
- pressure decreased to – 30 mmHg at 5 minutes 
- 3 minutes of – 30 mmHg 
- pressure gradually decreased from – 30 mmHg to – 60 mmHg over a 10 minute 
period, from 8 – 18 minutes.  
- pressure stable at – 60 mmHg for 3 minutes, from 18 to 21 minutes. 
- pressure raised to 0 mmHg (atmospheric pressure) at 21 minutes 
- 5 minutes post experiment recording 
- the experiment lasted a total of 21 minutes 
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If the subject showed signs or symptoms of syncope during the period of linear pressure 
drop (8 – 18 min), the pressure was raised to 0 mmHg, and the experiment continued with 
5 minutes of post experiment recording. 
 
Figure 3. Protocol timeline with relations to negative pressure and flags.  Statistics (table 
2) were calculated from 4 periods: period 1: 120s – 240s before Flag 2, period 2: 0s – 60s 
before Flag 4, period 3: 0s – 60s after Flag 4, period 4: 120s – 240s after Flag 4 
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Results 
General 
See fig 3. and 4. for illustrations. The main finding is that mean arterial blood pressure is 
rater stable during a simulated hemorrhage, and when MAP finally decreases or show a 
tendency to decrease, this inevitably leads to syncope. This is in accordance with our 
hypothesis and clinical experience that a drop in MAP is occurring late in the 
development of hemorrhagic shock. 7 out of 10 subjects fainted before the end of the 
period with increasing negative pressure. All subjects with near-syncope had one or more 
of the symptoms: dizziness, nausea, cold sweat, warm flushes or reduced vision. 
Characteristically there was a sudden bradycardia that preceded a drop in blood pressure. 
No subjects actually fainted due to the prompt decompression of the chamber.  
Figure 4. illustrates how SV decreases, almost in linear fashion. HR increases, but there is 
a great variability between subjects, and the absolute increase in HR is rater small. CO 
decreases, but the decrease in CO is to some degree buffered by the increased HR. TPR 
increases and the measurements of forearm SkBF and FVR show that the skin does 
participate in a general vasoconstriction.  
 
Subjects 
The subjects were recruited by putting up posters on the campus. The criteria to 
participate were filled by all individuals. These were to be a healthy individual between 
18-30 years, non-smoker and not use medication except contraceptive pills. 
 
Person Sex Height 
(cm) 
Weight 
(kg) 
BMI Exercise 
(h/week) 
Max 
LBNP 
LBNP 
aborted 
Pilot M 181 80 24,4 3 -55 Y 
A F 170 63 21,8 6 -40 Y 
B F 168 53 18,8 5,5 -60 N 
C M 175 73 23,8 8 -45 Y 
D F 167 55 19,7 2 -60 N 
E F 165 67 24,6 5 -56 Y 
F M 182 85 25,7 14 -60 N 
G M 175 70 22,9 3,5 -44 Y 
H M 184 80 23,6 10 -41 Y 
I F 165 50 18,4 12 -51 Y 
J M 185 80 23,4 5 -56 Y 
Average  173,6 67,6 22,3 7,1 -51,3  
Median  172,5 68,5 23,1 5,75 -53,5  
Table 2. Subject anthropometrics. 
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Figure 4. Illustration of cardiovascular data from one subject: LBNP, MAP (black 
middle), SP (gray upper), DP (gray lower), CO, SV and HR. 
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Figure 5. Illustration of cardiovascular data from one subject: LBNP, SkBF, LDF-nas, 
LDF-fing- TPR, and FVR. 
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120-240 seconds before Flag 2 (1)     
 HR SV CO MAP SP DP 
W(28) 62,7 78,2 4,9 83,0 128,9 64,6 
W(9) 54,6 68,2 4,0 73,5 113,0 57,6 
W(47) 69,9 94,5 5,9 89,7 140,3 70,0 
0-60 seconds before Flag 4 (2)     
W(28) 88,2 39,9 3,6 72,7 102,4 59,3 
W(9) 77,1 31,8 2,9 59,5 88,6 47,3 
W(47) 99,1 53,3 4,3 85,2 119,1 71,2 
0-60 seconds after Flag 4 (3)     
W(28) 68,1 76,8 5,1 78,9 118,6 60,8 
W(9) 61,4 61,4 3,9 68,9 101,8 54,1 
W(47) 72,9 91,0 6,2 89,8 131,4 69,6 
120-240 seconds after Flag 4 (4)     
W(28) 55,6 81,8 4,3 82,3 123,9 65,2 
W(9) 49,8 68,2 3,6 75,4 111,6 58,5 
W(47) 62,1 93,9 5,1 90,3 134,6 70,1 
Change from 1 to 4       
W(28) -7,1 3,5 -0,5 -0,7 -5,0 0,7 
W(9) -4,8 0,0 -0,4 1,9 -1,4 0,9 
W(47) -7,7 -0,6 -0,7 0,6 -5,7 0,1 
Change from 2 to 3       
W(28) -20,2 36,9 1,5 6,1 16,1 1,5 
W(9) -15,7 29,6 1,0 9,4 13,2 6,7 
W(47) -26,2 37,7 1,9 4,6 12,2 -1,6 
Change from 3 to 4       
W(28) -12,5 5,0 -0,7 3,5 5,3 4,4 
W(9) -11,6 6,8 -0,3 6,5 9,9 4,5 
W(47) -10,7 2,9 -1,1 0,5 3,3 0,5 
Change from 1 to 2       
W(28) 25,5 -38,4 -1,3 -10,3 -26,5 -5,2 
W(9) 22,6 -36,4 -1,1 -14,0 -24,4 -10,3 
W(47) 29,2 -41,2 -1,5 -4,5 -21,2 -1,2 
%-change: 0,41 -0,49 -0,26 -0,12 -0,21 -0,08 
Table 3. Comparison of the variables HR, SV, CO, MAP, SP, and DP  
at the different stages in the protocol  
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Blood pressure  
Systolic pressure: in our trials, 4 of 10 persons had a SP <100bpm in the last minute 
before the LBNP was switched off. In the minute before the LBNP was switched off, the 
average SP was 102,4 mmHg. That is a decrease of 26,5 mmHg, compared to the period 
before the LBNP was applied. 
 
Diastolic pressure: in the minute before the LBNP was switched off, the average DP was 
59,3 mmHg, which is a decrease of 5,2 mmHg compared to the period before the LBNP 
was switched on. 
 
Mean arterial pressure: in the minute before the LBNP was applied, the average MAP 
was 72,7 mmHg. That is a decrease of 10,3 mmHg, compared to the pre-pressure period. 
 
 
Heart rate 
In our trials, 3 of 10 persons had a HR >100 bpm in the last minute before the LBNP was 
switched off. In the minute before the LBNP was switched off, the average HR was 88,2 
bpm. That is an increase of 25,5 bpm compared to the pre-LBNP period, and this is a 
significant increase.  
 
Stroke Volume  
In the minute before the lbnp was switched off, the average SV was 39,9 ml, which on 
average is a decrease of 38,4 ml compared to the pre-LBNP period.  
 
Cardiac output 
In the minute before the LBNP was switched off, the average CO was 3,6 l/min. That is a 
decrease of 1,3 l/min, compared to the period before the LBNP was switched on. 
 
Total peripheral resistance 
TPR increases during the LBNP period, but with increasing variability.  
 
Skin blood flow 
SkBF in measured distally, where the AVAs are abundant, there was a large variability in 
blood. This variation lasted throughout the experiment, and did not show any decrease. 
The SkBF on non-acral skin did have a linear small decrease during the increasing LBNP 
period. A marked increase in SkBF is seen when the pressure is released at 20 minutes. 
The FVR also increases in the same period, but not as distinctly as TPR.  
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Discussion 
I will discuss the cardiovascular variables one by one, and to a certain degree carefully 
speculate on the preliminary results 
 
Blood pressure 
It is striking to see how little the pressure changes despite the reduction in central blood 
volume available for the heart (fig.4). There is obviously a compensatory mechanism that 
has come into play to avoid syncope and reduced cerebral function as discussed in the 
introduction. 
 
Systolic pressure: the SP was reduced by 21% on average. All persons in the trial had a 
reduction in the SP. The variation was from a reduction of 44 mmHg to a reduction of 13 
mmHg. Clinically the palpation of peripheral pulses is used to predict internal 
incompressible hemorrhage, and often used to initiate resuscitation or confirm successful 
fluid resuscitation. The failure of palpating the radial pulse is considered a sign of 
systolic pressure below 90 mmHg. Our findings indirectly indicate that this is logical and 
sensible. The peripheral pulses are dependent on the SP, and SP have the largest decrease 
within the 3 defined arterial pressures. 
 
Diastolic pressure: the DP was reduced by 8% on average. 6 of 10 persons had a 
reduction in the DP. The 3 persons who were able to complete the protocol, all had an 
increase in the DP. The variation in the DP was from a reduction of 18 mmHg to an 
increase of 12 mmHg. This is interesting because it indicates that the prediction of a 
“survivor”, a person that is less susceptible to the effects of a hemorrhage, has an 
increased ability to sustain the DP. DP is very dependent on the resistance to flow, and 
further research in this field should include different measures to look at how the body, 
and the sympathetic nervous system, addresses the different mechanisms to increase 
TPR.      
 
Mean Arterial Pressure: the MAP was reduced by 12% on average. 8 of 10 persons had a 
reduction in the MAP. The 2 persons, who had an increase in MAP, both completed the 
trial. The last persons, who completed the protocol, had a 4 mmHg reduction of MAP. 
This finding is not very surprising, the characteristic of these subjects will be studied in 
detail in our further analyzes, is there something special in of these subjects responses to 
LBNP challenge. 
 
 
Heart rate 
30% of the persons in our trial had a HR above 100 bpm during their last minute of 
LBNP challenge. This indicates that focusing solely on the absolute HR can be an 
unreliable predictor to show whether a person is about to enter a state of hypovolemic 
shock. The change in HR is significant, but this may be because the pre-LBNP period 
recordings were taken from a subject with relatively little stress. In a pre-hospital trauma 
setting the patient could have a substantial tachycardia from stress, pain, arousal etc, 
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which is independent of a developing hemorrhage. Therefore a significant increase in HR 
could not be expected from all from patients, even when they are bleeding internally. In 
our experiment the HR was increased with 41% on average, but the variation between 
individuals was from 10 bpm to 47 bpm increase. This illustrates that it is difficult to set 
an absolute limit to decide when the chances of an increase in HR is representing a 
hemorrhage. A close look at the HR in figure 6 also reveals a large intravariability. When 
HR is used for monitoring a patient, HR has to be recorded for quite some time allow for 
increases to be detected.  
Limitations to this study is that the LBNP-method is not representative enough when 
simulating a hemorrhage, even if the subjects faints (there are other unknown 
mechanisms in play). One can argue that a HR increase in the range of 50-90 bpm is low 
compared to clinical experience, and that in this range the parasympathetic effect of the 
vagus nerve is still in play. This will also give a higher HR variation compared to a HR 
driven totally by sympathetic input.   
 
Figure 6. Heart rate in one individual. Note the large intravariability in HR. 
 
 
Stroke volume 
The SV was nearly halved (49%). This indicates that SV could be a good predictor of a 
hypovolemic shock in development. In our trials the variation between the individuals 
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was between 15ml and 51ml reduction. The decrease in SV developed in a linear fashion 
in all subjects, with little intravariability. This makes it a more suitable candidate for a 
cardiovascular marker than HR. A closer look at the development of the stroke volume in 
figure 7 show how the steep decrease in pressure at 5 minutes is followed by proportional 
drop in SV. The drop is delayed for some seconds compared to the drop in pressure. 
There is no difference in SV pre-and post LBNP, which indicates that SV is less sensitive 
to stress. A medtech devise can maybe use SV in an algorithm to detect a developing 
hemorrhage. The challenge here would be to measure SV pre-hospitally, and even in 
hospital. The methods we used in our project are not very portable. 
 
Figure 7. Stroke volume in one individual. 
 
 
 
Cardiac output and total peripheral resistance 
The CO was reduced by 26% on average. All persons in the trial had a reduction in CO, 
and it varied between 0,5 l/min and 3,0 l/min. CO = SV x HR, and the reduction in SV is 
not compensated by an equivalent increase in HR. From the equation MAP = (SVxHR) x 
TPR, one can see that the raise in TPR is necessary to maintain MAP throughout the 
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experiment. One question that has to be raised is why HR did not increase more before 
syncope in those patients who fainted before the end of the increasing LBNP period.  
Skin blood flow 
The main effectors in temperature regulation in the thermoneutral zone are skin blood 
flow. When AVAs are synchronously constricted and dilated, this is taken as a measure 
of thermo neutrality. Many of the subjects did display this activity throughout the 
experiment, and this was rater surprising. In figure 5. SkBF is displayed as a 
measurement of brachial blood velocity. It is the AVAs that are responsible for the 
variations. As one can see, there is little vasoconstriction during the LBNP period. The 
blood flow recorded in non-acral skin show a small but (probably) significant reduction 
representing a vasoconstriction. This is part of the total activity to increase TPR. The skin 
in this area is without AVAs, and is controlled by active adrenergic vasoconstrictor 
system.  
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Conclusion 
It is not recommendable to try to draw any conclusions based on preliminary data, but 
maybe the analyzes so far confirm that in a progressive LBNP model to simulate 
hemorrhage: 
• MAP does not decrease until pre-syncope  
• SV decreases in a almost linear fashion 
• HR does increase, but there is large inter- and intravariability 
• SkBF contributes to increased TPR, but variations in SkBF due to temperature 
regulation persists 
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